Synthesis and biological evaluation of novel 9-functional heterocyclic coupled 7-deoxy-9-dihydropaclitaxel analogue

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 5, 2000, Pages 517-521

  Cheng, Qian ^a   Oritani, Takayuki ^a   Horiguchi, Tohru ^a   Yamada, Teiko ^a   Mong, Yan ^b,c  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEOXY 9 DIHYDROPACLITAXEL; DRUG ANALOG; PACLITAXEL; PACLITAXEL DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CANCER; MICROTUBULE ASSEMBLY; POLYMERIZATION; TUMOR CELLS AND CELL LINES;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICROTUBULES; NUCLEIC ACID SYNTHESIS INHIBITORS; PACLITAXEL; TAXOIDS; TUBULIN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034611439     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00031-7     Document Type: Article

References (37)

1. Wani M.C., Taylor H.L., Wall M.E., Coggon P., Mcphail A.T. J. Am. Chem. Soc. 93:1971;2325.
2. Suffness M. Ann. Rep. Med. Chem. 28:1993;305.
3. Rowinsky E.K., Cazenave L.A., Donehower R.C. J. Natl. Cancer Inst. 82:1990;1247.
4. Mcguire W.P., Rowinsky E.K., Rosenshein N.B., Grumbine F.C., Ettinger D.S., Armstrong D.K., Donehower R.C. Ann. Intern. Med. 111:1989;273.
5. Holmes, F. A.; Kudelka, A. P.; Kavanagh, J. J.; Huber, M. H.; Ajani, J. A.; Valero, V. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M. Eds.; ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 31-57.
6. Schiff P.B., Fant J., Horwitz S.B. Nature. 277:1979;665.
7. Manfredi J.J., Horwitz S.B. Pharmacol. Ther. 25:1984;83.
8. Nicolaou K.C., Dai W.-M., Guy R.K. Angew. Chem., Int. Ed. Engl. 33:1994;15.
9. Georg, G. I.; Boge, T. C.: Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. In Taxol: Science and Applications; Suffness, M. Ed.; CRC Press, Inc., Boca Raton, FL, USA, 1995, pp 317-375.
10. Chen S.H., Huang S., Wei J., Farina V. J. Org. Chem. 58:1993;4520.
11. Yuan H., Kingston D.I. Tetrahedron. 55:1999;9089.
12. Guéritte-Voegelein, F.; Guénard, D.: Dudois, J.; Wahl, A.; Marder, R.; Muller, R.; Lund, M.; Bricard, L.; Potier, P. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M. Eds.; ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 189-202.
13. Chen, S. H.; Farina, V. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M. Eds.; ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 247-261.
14. Liang X., Kingston D.G.I., Long B.H., Farichild C.A., Johnston K.A. Tetrahedron. 53:1997;3441.
15. Wittman M.D., Alstadt T.J., Kadow J.F., Vyas D.M., Johnson K., Farichild C., Long B. Tetrahedron Lett. 40:1999;4943.
16. Marder-Karsenti R., Dubois J., Bricard L., Guénard D., Guéritte-Voegelein F. J. Org. Chem. 62:1997;6631.
17. Gunatilaka A.A.L., Ramdayal F.D., Sarragiotto M.H., Kingston D.G.I., Sackett D.L., Hamel E. J. Org. Chem. 64:1999;2694.
18. Commerçon, A.; Bourzat, J. D.; Didier, E.; Lavelle, F. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M. Eds.; ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 233-246.
19. Guénard D., Guéritte-Voegelein F., Potier P. Acc. Chem. Res. 26:1993;160.
20. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M. Eds.; ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 203-216.
21. In The Chemistiy and Pharmacology of Taxol and Its Derivatives; Farina, V. Ed.; Elsevier, Amsterdam, The Netherlands, 1995, pp 165-254.
22. In Taxane AnticancerAgents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.: Vyas, D. M. Eds.; ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 276-287.
23. Bourgignon, J. J. In The Practice of Medicinal Chemistry; Wermuth, C. G. Ed.; Academic Press, 1996. pp 261-293.
24. Wiegerinck P.H.G., Fluks L., Hammink J.B., Mulders S.J.E., Groot F.M.H., Van Rozendaal L.M., Scheeren H.W. J. Org. Chem. 61:1996;7092.
25. Poujol H., Ahond A., Mourabit A., Chiaroni A., Poupat C., Riche C., Potier P. Tetrahedron. 53:1997;5169.
26. Poujol H., Mourabit A., Ahond A., Poupat C., Potier P. Tetrahedron. 53:1997;12575.
27. Matovic, R. and Saicic, R. N. J. Chem. Soc., Chem. Commun., 1998, 1745
28. Graf, E., Weinandy, S., Koch, B. and Breitmaier, E. Liebigs Ann. Chem. 1986, 1147
29. Appendino O., Gariboldi P., Pisetta A., Bombardelli E., Gabetta B. Phytochemistry. 31:1992;4253.
30. Cheng Q., Oritani T., Horiguchi T. Tetrahedron. 55:1999;12099.
31. In addition to 12, the 10-hydroxy-2-benzoyl-2, 10, 13-trideacetyl-7-deacetoxy-13-oxo baccatine IV was obtained in a small amounts.
32. + 1031.4432, found 1031.4423.
33. Mukaiyama T., Shiina I., Iwadare H., Saitoh M., Nishimura T., Ohkawa N., Sakoh H., Nishimura K., Tani Y., Hasegawa M., Yamada K., Saitoh K. Chem. Eur. 5:1999;121. and references cited therein.
34. All S.M., Hoemann M.Z., Aubé J., Mistcher L.A., Georg G.I., Mccall R., Jayasinghe L.R. J. Med. Chem. 38:1995;2821. .For review see ref 9.
35. Samaranaye G., Magri N.F., Jitrangsri C., Kingston D.G.I. J. Org. Chem. 56:1991;5114.
36. Bhalla K., Ibrado A.M., Tourkina E., Tang C., Mahoney M.E., Huang Y. Leukemia (Baltimore). 7:1993;563.
37. Appendino O., Belloro E., Jakupovic S., Danieli B., Jakupovic J., Bombardelli E. Tetrahedron. 55:1999;6567. and see refs 26 and 35.